Disease modelling and drug discovery for hypertrophic cardiomyopathy using pluripotent stem cells: how far have we come?

Eur Heart J. 2018 Nov 14;39(43):3893-3895. doi: 10.1093/eurheartj/ehy388.

Authors

Chi Keung Lam^{1

2}, Joseph C Wu^{1

2

3}

Affiliations

¹ Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.
² Department of Medicine, Division of Cardiology, Stanford University School of Medicine, Stanford, CA, USA.
³ Deparment of Radiology, Stanford University School of Medicine, Stanford, CA, USA.

No abstract available

Publication types

Comment

MeSH terms

Arrhythmias, Cardiac
CRISPR-Cas Systems
Cardiomyopathy, Hypertrophic / genetics*
Drug Discovery
Humans
Induced Pluripotent Stem Cells*
Myocytes, Cardiac
Pluripotent Stem Cells*

Grants and funding